Skip to search formSkip to main contentSkip to account menu

cisplatin-epinephrine therapeutic implant

Known as: CEG, CDDP/epi gel, Cisplatin-E Therapeutic Implant 
An injectable gel comprised of a collagen matrix containing the inorganic platinum (Pt) agent cisplatin and the sympathomimetic agent epinephrine… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Cisplatin (CDDP) is a potent anti-carcinogen that is widely used for various solid tumors; however, its clinical application is… 
Highly Cited
2007
Highly Cited
2007
The granulin‐epithelin precursor (GEP/PCDGF), a 68–88 kDa secreted glycoprotein, has been shown to be an important growth and… 
2006
2006
PurposeThis retrospective study evaluated the effects of neoadjuvant chemotherapy in advanced gastric cancer.MethodsBetween 2002… 
Highly Cited
2002
Highly Cited
2002
Only 20–30% of patients with refractory or recurrent germ cell tumors (GCT) are cured by salvage chemotherapy. Irinotecan, a new… 
Highly Cited
2000
Highly Cited
2000
The current study was conducted to evaluate retrospectively the effects of three kinds of regimens used in transcatheter arterial… 
Highly Cited
1999
Highly Cited
1999
In a cross-sectional study of 164 participants aged 21 to 91, the authors examined age differences on two implicit tests… 
1996
1996
PURPOSE Patients with locally advanced squamous cell carcinoma of the cervix have a poor prognosis when treated by standard… 
1986
1986
Nephrotoxicity, the dose-limiting toxicity of cis-diamminedichloroplatinum(II) (CDDP), is ameliorated when administered in… 
Highly Cited
1984
Highly Cited
1984
The development and evaluation of a post-column reaction detector sensitive to platinum(II) complexes is presented in which…